Veterinary Medicines

Drontal Dog Tasty Bone XL 525/504/175 mg tablets

Authorised
  • Praziquantel
  • Pyrantel embonate
  • Febantel
Download as PDF

Product identification

Medicine name:
Drontal Dog Tasty Bone XL 525/504/175 mg tablets
Drontal Large Dog Tasty 525/504/175 mg tabletten
Active substance:
  • Praziquantel
  • Pyrantel embonate
  • Febantel
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Praziquantel
    175.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    504.00
    milligram(s)
    /
    1.00
    Tablet
  • Febantel
    525.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Container material: Blisters formed from PA/Alu/PE foil and sealed with Alu/PE foil. Container size: Cartons containing 48 tablets.
  • Container material: Blisters formed from PA/Alu/PE foil and sealed with Alu/PE foil. Container size: Cartons containing 24 tablets.
  • Container material: Blisters formed from PA/Alu/PE foil and sealed with Alu/PE foil. Container size: Cartons containing 8 tablets.
  • Container material: Blisters formed from PA/Alu/PE foil and sealed with Alu/PE foil. Container size: Cartons containing 4 tablets.
  • Container material: Blisters formed from PA/Alu/PE foil and sealed with Alu/PE foil. Container size: Cartons containing 2 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Europeenne De Pharmacotechnie Europhartech
  • KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 119735
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0335/002
Concerned member states:
  • Austria
  • Denmark
  • Finland
  • France
  • Germany
  • Iceland
  • Italy
  • Netherlands
  • Norway
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 26/01/2022
Download

Summary of Product Characteristics

English (PDF)
Published on: 26/08/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."